ApprovedNeuroendocrine / acromegaly

Octreotide

Brand examples:SandostatinSandostatin LAR

Class
Neuroendocrine / acromegaly
Route
SC/IV/IM depot
Frequency
Multiple
GLP-1 relevance
No

How it works

Somatostatin analog

Approved & studied uses

Acromegaly; neuroendocrine tumors; carcinoid/VIPoma symptoms

Regulatory status

Approved

Safety notes

Prescription-only; depot and immediate-release differ.

Sources

Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.